Public funding and pricing
Public funding and pricing The Norwegian Medical Products Agency is responsible for assessing the cost-effectiveness of and setting maximum prices for prescription-only-medicines.
Changes to the Submission Process for Documentation in Health Technology Assessments from September 1st
Published:
|
Updated:
Strengthening the System for the Assessment of Medical Devices in the specialist health care services
Published:
FINOSE becomes Joint Nordic HTA-Bodies, JNHB
Published:
Switching between a reference product and a biosimilar
Published:
|
Updated: